The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Acer Therapeutics Inc. - Discusses Reformulated Assets to Develop COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020

SNNLive spoke with Chris Schelling, CEO and Founder of Acer Therapeutics Inc. (NASDAQ: ACER), via Zoom

Share With

Thursday, May 21, 2020

   

© 2020 Stock News Now